**Author details**

Bonnie L. Russell1,2†, Sibusiso T. Malindisa1†, Selisha A. Sooklal1† and Monde Ntwasa1 \*

1 Department of Life and Consumer Sciences, University of South Africa, Johannesburg, South Africa

2 Buboo (Pty) Ltd., The Innovation Hub, Gauteng, Pretoria, South Africa

\*Address all correspondence to: ntwasmm@unisa.ac.za

† These authors contributed equally.

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Current Advances in Immune Checkpoint Therapy DOI: http://dx.doi.org/10.5772/intechopen.107315*
